% Expired Patents = 50.0

Forward Citations = 2

Loading Chart...

3 inventors (with patents filed for the assignee):

Ritu Aneja (4 out of 11 patents)

Padmashree C G Rida (3 out of 3 patents)

Venkata Subba Rao Mukkavilli (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 10242153 - Method for determining the risk profile of neoplastic tissue (2019-03-26),

2. 10213448 - Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof (2019-02-26),

3. 9857354 - Compositions and methods for prognosis and treatment of neoplasm (2018-01-02),

4. 9589100 - Method for determining the risk profile of neoplastic tissue (2017-03-07),

Company Overview

Novazoi Theranostics is a leading biotechnology company specializing in the development of innovative diagnostic tools and personalized treatment solutions for various diseases. Our cutting-edge technologies and expertise in molecular biology enable us to provide accurate and timely diagnosis, leading to more effective and targeted therapies for patients. With a strong commitment to advancing precision medicine, Novazoi Theranostics is dedicated to improving patient outcomes and transforming the healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#4 in Rancho Palos Verdes, CA

#14,058 in California

#60,671 in US

Rancho Palos Verdes, CA, United States of America

Novazoi Theranostics

Forward Citations = 2

3 inventors:

Ritu Aneja (4 out of 11 patents)

Padmashree C G Rida (3 out of 3 patents)

Venkata Subba Rao Mukkavilli (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novazoi Theranostics. Retrieved from https://idiyas.com/company/novazoi-theranostics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]